Early stage med device co. developing a subcutaneous continuous blood pressure monitor for patients with uncontrolled hypertension.
CoraVie Medical has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in March 2024.
CoraVie Medical's investors include National Science Foundation, Groove Capital, gbeta, gBETA Medtech.
CoraVie Medical is headquartered in Minneapolis, United States.
Early stage med device co. developing a subcutaneous continuous blood pressure monitor for patients with uncontrolled hypertension.
CoraVie Medical is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CoraVie Medical — Funding & Investors." VCBacked, March 1, 2024, https://www.vcbacked.co/company/coravie-medical. Accessed August 13, 2026.
VCBacked. (2024). CoraVie Medical — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/coravie-medical
{{cite web |title=CoraVie Medical — Funding & Investors |url=https://www.vcbacked.co/company/coravie-medical |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated